Target intelligence / Profile preview

Extracellular Purine Nucleotides and Phosphorylated Molecular Patterns (eATP/PAMPs)

Target
eATP/PAMPs
Molecular classification
Nucleotide, Lipopolysaccharide, Damage-associated molecular pattern, Pathogen-associated molecular pattern
01

Overview

Extracellular Purine Nucleotides and Phosphorylated Molecular Patterns are a heterogeneous group of signaling molecules that act as potent triggers for the innate immune system (Di Virgilio et al., 2020). Adenosine triphosphate (ATP) and adenosine diphosphate (ADP), while primarily intracellular, are released into the extracellular space during cell stress or necrosis, where they function as Damage-Associated Molecular Patterns (DAMPs) by activating purinergic P2 receptors (Trautmann, 2009). Similarly, phosphorylated Pathogen-Associated Molecular Patterns (PAMPs), such as the lipid A component of bacterial lipopolysaccharide (LPS), initiate inflammatory cascades through Toll-like receptors (Peters et al., 2014). In pathological conditions like sepsis and acute kidney injury, the systemic accumulation of these phosphorylated molecules drives hyper-inflammation and organ failure. Therapeutic interventions, such as the administration of alkaline phosphatase (e.g., ilofolstat), target these molecules by enzymatically removing their phosphate groups (Pickkers et al., 2018). This dephosphorylation detoxifies endotoxins and converts pro-inflammatory ATP into adenosine, which exerts anti-inflammatory and tissue-protective effects.

Other names
Extracellular nucleotidesPhosphorylated Damage-Associated Molecular PatternsPhosphorylated Pathogen-Associated Molecular PatternsDanger signalsAlarminseATPeADP
02

Mechanism of action

Enzymatic dephosphorylation and detoxification of pro-inflammatory ligands into non-toxic or anti-inflammatory metabolites.

03

Biological functions

Immune responseSignal transductionInflammationPlatelet activationVasodilationCell death signaling
04

Disease associations

SepsisAcute kidney injurySystemic Inflammatory Response SyndromeChronic inflammationAutoimmune disease
05

Safety considerations

Disruption of purinergic-mediated platelet aggregationAlteration of vascular tone regulationPotential for excessive immunosuppressionHypocalcemia (rarely associated with high-dose phosphatase therapy)
06

Interacting drugs

Ilofolstat (recombinant human alkaline phosphatase)

2 more in the full profile.

07

Biomarkers

Plasma ATP levelsEndotoxin activity assayC-reactive proteinProcalcitoninUrinary N-acetyl-beta-D-glucosaminidase

Beyond the preview

Go deeper on Extracellular Purine Nucleotides and Phosphorylated Molecular Patterns (eATP/PAMPs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular Purine Nucleotides and Phosphorylated Molecular Patterns (eATP/PAMPs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call